Scarica l'app Stockscreener
29.06
3.84%
-1.16
Dopo l'orario di chiusura:
29.13
0.07
+0.24%
Precedente Chiudi:
$30.22
Aprire:
$30.68
Volume 24 ore:
417.62K
Relative Volume:
1.25
Capitalizzazione di mercato:
$211.17M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-17.72
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
-8.39%
1M Prestazione:
-7.45%
6M Prestazione:
+123.54%
1 anno Prestazione:
+115.16%
Intervallo 1D:
$28.95
$30.97
Intervallo di 1 settimana:
$28.95
$33.50
Portata 52W:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Confronta VOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
29.06 | 211.17M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Can Vor Biopharma Inc. stock maintain operating marginsJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Vor Bio (VOR) Shares Positive Phase 3 Study Results for Telitaci - GuruFocus
Can Vor Biopharma Inc. stock resist sector downturnsPortfolio Update Summary & Free Risk Controlled Daily Trade Plans - newser.com
Vor Biopharma (VOR) 10% owners sell shares worth $3 million By Investing.com - Investing.com Nigeria
Vor Biopharma (VOR) 10% owners sell shares worth $3 million - Investing.com India
Baird Upgrades Vor Biopharma (VOR) - Nasdaq
Baird Upgrades Vor Biopharma to Outperform From Neutral, Adjusts Price Target to $64 From $20 - MarketScreener
Vor Biopharma's Telitacicept: A Pipeline In Itself? - RTTNews
VOR Biopharma (VOR) Receives Significant Analyst Upgrade from Ba - GuruFocus
Can machine learning forecast Vor Biopharma Inc. recoveryWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
Baird upgrades Vor Biopharma stock rating to Outperform on telitacicept potential - Investing.com
Baird Upgrades Vor Biopharma, Inc. (VOR) to Outperform - StreetInsider
Combining price and volume data for Vor Biopharma Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Vor Bio's Collaborator Delivers Positive Results For Telitacicept In Autoimmune Disorder That Impacts Tears - Benzinga
Vor Biopharma stock rises after positive Phase 3 results for Sjögren’s treatment By Investing.com - Investing.com South Africa
Vor Biopharma stock rises after positive Phase 3 results for Sjögren’s treatment - Investing.com Australia
Vor Bio rises after partner RemeGen succeeds in Sjögren’s disease study - Seeking Alpha
Vor Bio (VOR) and RemeGen Report Strong Phase 3 Results for Teli - GuruFocus
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Reprogrammed Interchange Llc Sells 48,884 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Sells $2,549,123.94 in Stock - MarketBeat
Vor Biopharma Inc.'s (NASDAQ:VOR) Intrinsic Value Is Potentially 55% Above Its Share Price - simplywall.st
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock - Investing.com
Is Vor Biopharma Inc. stock poised for growth2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Vor Biopharma Inc. stock2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
What indicators show strength in Vor Biopharma Inc.Portfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
What analyst consensus says on Vor Biopharma Inc. stock2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Is Vor Biopharma Inc. meeting your algorithmic filter criteria2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Vor Biopharma's (VOR) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 70,763 Shares - MarketBeat
Vor biopharma $3.5m stock sale by ten percent owner - Investing.com Australia
Relative strength of Vor Biopharma Inc. in sector analysisJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 02:38:01 - newser.com
Vor biopharma $3.5m stock sale by ten percent owner By Investing.com - Investing.com Australia
Can momentum traders help lift Vor Biopharma Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com
Applying sector rotation models to Vor Biopharma Inc.2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Will Vor Biopharma Inc. bounce back from current support2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Reprogrammed Interchange Llc Sells 7,901 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 32,451 Shares - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 1,400 Shares - MarketBeat
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vor Biopharma Inc Azioni (VOR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10% Owner |
Oct 14 '25 |
Sale |
30.32 |
33,668 |
1,020,787 |
1,278,118 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 13 '25 |
Sale |
32.44 |
22,006 |
713,786 |
1,311,786 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):